Patents by Inventor Koubun YASUDA

Koubun YASUDA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR TREATING OR ALLEVIATING ENDOMETRIOSIS WITH IL-33 ANTAGONIST
    Publication number: 20220372130
    Abstract: Based on the identification of IL-33 as an exacerbating factor in endometriosis and adenomyosis uteri, a method for treating or alleviating endometriosis or adenomyosis uteri, involves administering an IL-33 antagonist, which is capable of inhibiting the function of IL-33. The IL-33 antagonist is useful for treating, preventing or alleviating endometriosis and uterine adenomyosis uteri.
    Type: Application
    Filed: July 15, 2022
    Publication date: November 24, 2022
    Inventors: Tomohiro YOSHIMOTO, Joseph M. PALUMBO, Violetta I. STONE, Toru KATO, Koubun YASUDA
  • IL-33 antagonist-containing therapeutic agent for endometriosis
    Patent number: 11492398
    Abstract: Based on the identification of IL-33 as an exacerbating factor in endometriosis and adenomyosis uteri, a therapeutic agent for endometriosis and adenomyosis uteri has an IL-33 antagonist, which is capable of inhibiting the function of IL-33. The IL-33 antagonist is useful for treating, preventing or alleviating endometriosis and uterine adenomyosis uteri.
    Type: Grant
    Filed: August 31, 2018
    Date of Patent: November 8, 2022
    Assignees: MITSUBISHI TANABE PHARMA CORPORATION, HYOGO COLLEGE OF MEDICINE
    Inventors: Tomohiro Yoshimoto, Joseph M. Palumbo, Violetta I. Stone, Toru Kato, Koubun Yasuda
  • IL-33 ANTAGONIST-CONTAINING THERAPEUTIC AGENT FOR ENDOMETRIOSIS
    Publication number: 20200190182
    Abstract: Based on the identification of IL-33 as an exacerbating factor in endometriosis and adenomyosis uteri, a therapeutic agent for endometriosis and adenomyosis uteri has an IL-33 antagonist, which is capable of inhibiting the function of IL-33. The IL-33 antagonist is useful for treating, preventing or alleviating endometriosis and uterine adenomyosis uteri.
    Type: Application
    Filed: August 31, 2018
    Publication date: June 18, 2020
    Inventors: Tomohiro YOSHIMOTO, Joseph M. PALUMBO, Violetta I. STONE, Torn KATO, Koubun YASUDA